Pharmafile Logo
Pharmafocus logo
Advanced Search

Pomalidomide

Showing 2 posts of 2 posts found.

Celgene image

Celgene’s blood cancer pill too expensive for NHS

February 13, 2015
Sales and Marketing Celgene, NHS, NICE, Pomalidomide, imnovid, myeloma

NICE has decided not to recommend Celgene’s Imnovid for treating patients with multiple myeloma – a cancer that affects white …

News
Celgene image

Celgene predicts trio of blockbusters

June 5, 2013
Sales and Marketing Celgene, Pomalidomide, Revlamid, Velcade

Europe’s medicines committee the CHMP has just adopted a positive opinion for Celgene’s new multiple myeloma treatment Pomalidomide Celgene (pomalidomide). …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025